UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

 

the Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported):
April 25, 2012

 

USANA HEALTH SCIENCES, INC.

(Exact name of registrant as specified in its charter)

 

Utah

(State or other jurisdiction of incorporation)

 

0-21116

 

87-0500306

(Commission File No.)

 

(IRS Employer Identification

 

 

Number)

 

3838 West Parkway Boulevard
Salt Lake City, Utah 84120
(Address of principal executive offices, Zip Code)

 

Registrant’s telephone number, including area code: (801) 954-7100

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 5.07               Submission of Matters to a Vote of Security Holders.

 

The Company held its Annual Meeting of Shareholders on April 25, 2012.  A total of 13,562,074 shares (approximately 90%) of the issued and outstanding shares of USANA common stock were represented by proxy or in person at the meeting.  The following matters were submitted and voted upon at the Annual Meeting:

 

1.               USANA shareholders voted to elect five individuals to the Board of Directors for the succeeding year as set forth below:

 

Name

 

Number of
Shares For

 

Number of
Shares
Withheld

 

Number of
Shares
Abstaining

 

Broker
Non-Votes

 

 

 

 

 

 

 

 

 

 

 

Myron W. Wentz, PhD

 

12,630,749

 

93,156

 

 

838,169

 

Ronald S. Poelman

 

12,654,013

 

69,892

 

 

838,169

 

Robert Anciaux

 

12,654,113

 

69,792

 

 

838,169

 

Jerry G. McClain

 

12,668,653

 

55,252

 

 

838,169

 

Gilbert A. Fuller

 

11,295,802

 

1,428,103

 

 

838,169

 

 

2.               USANA shareholders voted to ratify the Board’s selection of PricewaterhouseCoopers LLC as our independent registered public accountant for fiscal year 2012 as set forth below:

 

Number of
Shares For

 

Number of
Shares
Withheld

 

Number of
Shares
Abstaining

 

Broker
Non-Votes

 

 

 

 

 

 

 

 

 

13,514,824

 

39,050

 

8,200

 

0

 

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

USANA HEALTH SCIENCES, INC.

 

 

 

 

 

By:

/s/ G. Douglas Hekking

 

G. Douglas Hekking, Chief Financial Officer

 

 

Date: April 30, 2012

 

 

3